The CLDN5 locus may be involved in the vulnerability to schizophrenia

European Psychiatry : the Journal of the Association of European Psychiatrists
Z-Y SunGwynneth P Hemmings

Abstract

The present study was designed to detect three single nucleotide polymorphisms (SNPs) located on 22q11 that was thought as being of particularly importance for genetic research into schizophrenia. We recruited a total of 176 Chinese family trios of Han descent, consisting of mothers, fathers and affected offspring with schizophrenia for the genetic analysis. The transmission disequilibrium test (TDT) showed that of three SNPs, rs10314 in the 3'-untranslated region of the CLDN5 locus was associated with schizophrenia (chi(2) = 4.75, P = 0.029). The other two SNPs, rs1548359 present in the CDC45L locus centromeric of rs10314 and rs739371 in the 5'-flanking region of the CLDN5 locus, did not show such an association. The global chi-square (chi(2)) test showed that the 3-SNP haplotype system was not associated with schizophrenia although the 1-df test for individual haplotypes showed that the rs1548359(C)-rs10314(G)-rs739371(C) haplotype was excessively non-transmitted (chi(2) = 5.32, P = 0.02). Because the claudin proteins are a major component for barrier-forming tight junctions that could play a crucial role in response to changing natural, physiological and pathological conditions, the CLDN5 association with schizophrenia may b...Continue Reading

References

Jan 30, 1976·Science·M M Singh, S R Kay
Mar 1, 1982·Archives of General Psychiatry·L H StormsC Wright
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·M KarayiorgouV K Lasseter
Mar 15, 1994·American Journal of Medical Genetics·A E PulverG Nestadt
Mar 15, 1994·American Journal of Medical Genetics·H CoonM Leppert
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·K MoritaS Tsukita
Jun 11, 1999·Journal of the American Society of Nephrology : JASN·A S FanningJ M Anderson
Jun 17, 1999·Trends in Cell Biology·S Tsukita, M Furuse
Oct 6, 1999·Biological Psychiatry·A S Bassett, E W Chow
Dec 14, 1999·The American Journal of Pathology·L M DallastaC L Achim
Apr 17, 2001·American Journal of Medical Genetics·K YamamotoG A Rouleau
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·M F EganD R Weinberger
Aug 10, 2001·American Journal of Medical Genetics·A De LucaG Novelli
Nov 21, 2001·Nature Reviews. Genetics·E A Lindsay
Feb 15, 2002·Lancet·Kieran C Murphy
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Hui LiuMaria Karayiorgou
Jul 20, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Tae-Won ParkDaehee Kang
Sep 10, 2002·Human Molecular Genetics·Hélène JacquetThierry Frébourg
Apr 23, 2003·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·I KremerR P Ebstein
Oct 1, 1994·TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·A Darvasi, M Soller

❮ Previous
Next ❯

Citations

Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Yuri PersidskyGeorgette D Kanmogne
Aug 29, 2000·Journal of Dermatological Science·Y XieJ W Streilein
Nov 18, 2008·Schizophrenia Bulletin·Hiroki IshiguroTadao Arinami
Jul 12, 2007·Molecular Medicine·Birgit H FunkeRaju Kucherlapati
Jun 9, 2016·Human Genome Variation·Matthew S HestandJoris R Vermeesch
Dec 7, 2007·Behavioural Brain Research·Sulev KõksLeonard C Schalkwyk
Feb 14, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Lin XieJun Wei
Jul 19, 2011·Journal of Cellular and Molecular Medicine·Ilana MandelAriel Miller
Sep 27, 2005·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Jun Wei, Gwynneth P Hemmings
Jan 4, 2013·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Olaoluwa OkusagaTeodor T Postolache
May 10, 2015·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Binod Kumar Yadav, Byoung-Soo Shin
Mar 17, 2015·Current Psychiatry Reports·Emily G SeveranceRobert H Yolken
Mar 9, 2017·Clinical and Experimental Pharmacology & Physiology·Vivek SrinivasanDaniel Ky Chan
Oct 11, 2005·Cell·Richard Daneman, Ben A Barres
Sep 29, 2017·Tissue Barriers·Conor Delaney, Matthew Campbell
Oct 11, 2017·Molecular Psychiatry·C GreeneM Campbell
Feb 10, 2018·Current Environmental Health Reports·Shannon Delaney, Mady Hornig
Apr 17, 2013·Physiological Reviews·Dorothee Günzel, Alan S L Yu
Aug 21, 2019·International Journal of Molecular Sciences·Yosuke HashimotoMasuo Kondoh
Jun 22, 2020·European Archives of Psychiatry and Clinical Neuroscience·Ayşe UstaMustafa Bozkurt
Jan 30, 2019·Fluids and Barriers of the CNS·Chris GreeneMatthew Campbell
Sep 13, 2012·Experimental and Therapeutic Medicine·Su Kang KimJoo-Ho Chung
May 1, 2020·Biochimica Et Biophysica Acta. Biomembranes·Yosuke Hashimoto, Matthew Campbell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.